Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -42.36%-17.98K | -241.45%-14.77K | 82.63%-27.58K | 55.75%-5.63K | 62.48%-5K | 90.98%-12.63K | -159.78%-4.33K | 61.27%-158.76K | 84.17%-12.72K | 95.61%-13.32K |
| Net income from continuing operations | 28.51%-45.21K | 64.61%-30.49K | 91.63%-256.81K | 98.17%-50.5K | 41.11%-56.93K | 33.56%-63.24K | 29.74%-86.15K | -349.37%-3.07M | -749.62%-2.75M | 29.70%-96.67K |
| Asset impairment expenditure | --0 | --0 | --0 | ---- | ---- | --195 | --1.64K | 840.29%2.45M | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---32.45K | --0 |
| Other non cashItems | 18.21%7.16K | 7.99%6.43K | -89.56%24.02K | --9.97K | --2.05K | --6.05K | --5.95K | 284.64%230.08K | ---- | ---- |
| Change In working capital | -54.77%20.08K | -87.49%9.29K | -9.06%205.2K | -61.08%34.9K | -37.99%51.69K | 199.14%44.39K | -23.80%74.23K | 124.79%225.64K | 647.23%89.67K | 142.13%83.35K |
| -Change in receivables | 111.42%456 | -49.67%5K | 136.66%2.83K | 81.24%-1.88K | -102.24%-1.24K | 91.69%-3.99K | 298.28%9.94K | -121.88%-7.71K | -124.65%-10.01K | 829.43%55.35K |
| -Change in prepaid assets | ---- | ---- | 485.79%20.44K | 115.78%1.24K | 223.58%21.92K | -126.71%-2.72K | --0 | -1,254.99%-5.3K | -149.37%-7.89K | 202.02%6.77K |
| -Change in payables and accrued expense | -61.61%19.62K | -93.33%4.29K | -23.77%181.94K | -66.96%35.53K | 46.10%31.01K | 838.30%51.11K | -44.95%64.29K | 264.21%238.65K | 341.31%107.56K | 111.56%21.22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -42.70%-17.98K | -241.45%-14.77K | 82.63%-27.58K | 55.75%-5.63K | 62.26%-5.03K | 91.00%-12.6K | -159.78%-4.33K | 61.27%-158.76K | 84.17%-12.72K | 95.61%-13.32K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -118.22%-3.94K | 1,000.76%5.78K | 74.42%-636 | 96.16%-1.2K | 99.03%-11.56K | 113.40%21.65K | 100.48%525 |
| Net PPE purchase and sale | --0 | --0 | ---- | ---- | 1,000.76%5.78K | 74.42%-636 | 96.16%-1.2K | --0 | -96.45%33.21K | 100.48%525 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.95%-11.56K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | -118.22%-3.94K | 1,000.76%5.78K | 74.42%-636 | 96.16%-1.2K | 99.03%-11.56K | 113.40%21.65K | 100.48%525 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 20K | 15K | 0 | 0 | 0 | 0 | 0 | -80.02%188.1K | 0 | 0 |
| Net issuance payments of debt | --20K | --15K | --0 | --0 | --0 | --0 | --0 | --51.5K | --6.5K | --0 |
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -79.95%145K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -103.85%-8.4K | -102.89%-6.5K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --20K | --15K | --0 | --0 | --0 | --0 | --0 | -80.02%188.1K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -88.49%2.84K | -91.35%2.61K | 143.29%30.19K | -42.71%12.18K | -66.44%11.43K | -86.03%24.67K | 143.29%30.19K | -98.17%12.41K | -27.42%21.27K | -30.84%34.06K |
| Current changes in cash | 115.27%2.02K | 104.14%229 | -255.11%-27.58K | -207.24%-9.57K | 105.88%752 | 90.71%-13.24K | -103.37%-5.53K | 102.67%17.78K | 152.85%8.93K | 35.86%-12.8K |
| End cash Position | -57.48%4.86K | -88.49%2.84K | -91.35%2.61K | -91.35%2.61K | -42.71%12.18K | -66.44%11.43K | -86.03%24.67K | 143.29%30.19K | 143.29%30.19K | -27.42%21.27K |
| Free cash from | -35.84%-17.98K | -167.30%-14.77K | 82.63%-27.58K | -127.48%-5.63K | 75.06%-3.19K | 90.71%-13.24K | 76.98%-5.53K | 68.86%-158.76K | -97.61%20.49K | 96.91%-12.8K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.